Curt R. Hartman - Nov 7, 2024 Form 4 Insider Report for CONMED Corp (CNMD)

Role
President and CEO, Director
Signature
/s/ Thomas Fistek for Curt R. Hartman by Power of Attorney
Stock symbol
CNMD
Transactions as of
Nov 7, 2024
Transactions value $
-$277,892
Form type
4
Date filed
11/8/2024, 05:02 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $1.54M +30K +697.84% $51.30 34.3K Nov 7, 2024 Direct
transaction CNMD Common Stock Tax liability -$1.82M -24.3K -70.86% $74.76 10K Nov 7, 2024 Direct
holding CNMD Common Stock 83.5K Nov 7, 2024 Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD SARs (Stock Appreciation Rights) Options Exercise $0 -30K -20.23% $0.00 118K Nov 7, 2024 Common Stock 30K $51.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (20%) over a five year period.